Quoin Pharmaceuticals, Ltd. (QNRX) Balance Sheet
As of 2026-06-30 (10-Q), Quoin Pharmaceuticals, Ltd. (QNRX) reported total assets of $12.0M, total liabilities of $8.0M and shareholders' equity of $3.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $3.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
QNRXQuoin Pharmaceuticals, Ltd.Follow QNRX — free
—
Price chart with a free account
- Market cap
- 282.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2017 Dec 17 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 0.3 | 7.5 | 2.9 | 2.4 | 3.6 | 3.8 | 3.8 | |
| Short-term investments | — | — | — | — | — | — | 10.4 | 14.9 | 7.0 | |
| Current assets | 8.2 | 5.4 | 0.5 | 8.2 | 13.4 | 11.3 | 14.9 | 20.0 | 11.6 | |
| Total assets | 8.8 | 6.2 | 1.4 | 9.4 | 14.5 | 12.2 | 15.7 | 20.4 | 12.0 | |
| Current liabilities | 1.2 | 1.1 | 0.9 | 4.6 | 3.5 | 3.6 | 4.2 | 5.5 | 6.6 | |
| Total liabilities | — | — | 8.0 | 8.7 | 7.1 | 6.5 | 6.5 | 7.3 | 8.0 | |
| Shareholders' equity | 5.4 | -4.5 | -6.6 | 0.7 | 7.4 | 5.7 | 9.2 | 13.1 | 3.9 |
USD millions · SEC XBRL
Quoin Pharmaceuticals, Ltd. — questions
- How much cash does Quoin Pharmaceuticals, Ltd. have?
- $3.8M in cash and cash equivalents as of 2026-06-30.
- What are Quoin Pharmaceuticals, Ltd.'s total assets?
- $12.0M as of 2026-06-30.
- What is Quoin Pharmaceuticals, Ltd.'s shareholders' equity?
- $3.9M as of 2026-06-30.
Every figure on this page comes from Quoin Pharmaceuticals, Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.